bis
Market Research Report

A quick peek into the report

Europe Targeted Sequencing Market

Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033

 
Some Faq's

Frequently Asked Questions

The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033.

Targeted sequencing focuses on specific regions of the genome, offering cost-effective, high-depth analysis ideal for studying particular genes or variants. Whole genome sequencing (WGS), on the other hand, analyzes the entire genome, providing comprehensive data but at higher costs and lower coverage depth compared to targeted approaches.

Key trends in the Europe targeted sequencing market include rising demand for personalized medicine, advancements in next-generation sequencing (NGS) technologies, and increased adoption in oncology and rare disease research. The integration of AI and bioinformatics for data analysis, along with growing government support for genomic initiatives, is driving market expansion.

Sequencing manufacturers, CROs, CMOs, and CDMOs focusing on healthcare products can buy this report.

The following are some of the USPs of this report:

•    Market Growth Potential
•    Regulatory Framework
•    Market Dynamics
•    Market Opportunities
•    Detailed Segmentation such as Application, End User, Target Enrichment Method, Target Capture, and Product Type

Similar Product

You may also like

Targeted Sequencing Market - A Global and Regional Analysis
Published Year: 2024

Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Tar

The global targeted sequencing market was valued at $3,479.8 million in 2023 and is expected...